FDA approves Moderna's mRNA flu vaccine after initially refusing to review it

After refusing to even review it, the FDA has approved Moderna's mRNA seasonal flu vaccine.

The Food and Drug Administration (FDA) late Wednesday approved the nation’s first mRNA flu vaccine, manufactured by drugmaker Moderna.  The agency approved the shot for two separate age groups; people age 50 to 64, and for 65 years and older. Moderna said it will conduct a postmarket clinical trial to confirm the effec

FDA Approves First mRNA Flu Vaccine For Older Adults  Forbes

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday.

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

FDA approves first mRNA-based flu vaccine  CNN

FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Process  WSJ

The agency had initially refused to even review the application but reversed course after a public outcry.

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K., according to federal officials in a news release.